mHealth Mindfulness With Patients With Serious Illness and Their Caregivers
Piloting an mHealth-delivered Mindfulness Therapy With Patients With Serious Illness and Their Caregivers to Alleviate Symptoms of Anxiety
1 other identifier
interventional
162
1 country
3
Brief Summary
Older adults with serious illness and their caregivers have high rates of anxiety and limited access to effective, non-pharmacological treatments. A recent National Academy of Medicine report recommended increased emphasis on disseminating and implementing evidence-based psychotherapies in order to have maximal public health impact. Through this work, I will identify a sustainable and potentially scalable dyadic intervention and delivery model to manage symptoms of anxiety in older adults with serious illness and their caregivers in primary care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2022
Longer than P75 for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 7, 2021
CompletedFirst Posted
Study publicly available on registry
September 10, 2021
CompletedStudy Start
First participant enrolled
April 26, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 1, 2026
April 24, 2026
April 1, 2026
4.4 years
September 7, 2021
April 22, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Hospital Anxiety and Depression Scale - Anxiety Sub Scale
Anxiety scale with range from 0-21 with higher scores denoting highest anxiety
6 months
Hospital Anxiety and Depression Scale - Anxiety Sub Scale
Anxiety scale with range from 0-21 with higher scores denoting highest anxiety
8 weeks
Secondary Outcomes (3)
Hospital Anxiety and Depression Scale - Depression Sub Scale
6 months
Hospital Anxiety and Depression Scale - Depression Sub Scale
8 weeks
Perceived stress scale
8 weeks
Study Arms (2)
mindfulness coach
EXPERIMENTALMindfulness coach is an app that provides a training plan with 14 sequential levels, a "practice now" area with evidence-based mindfulness audio exercises, assessments using the Five-Factor Mindfulness Questionnaire Short Form (FFMQ-SF)90, and education about mindfulness an iOS- and Android-based app designed to deliver a mindfulness training course centered on Veteran's Affairs (VA) protocols. Developed by the VA's National Center for PTSD, the app provides an engaging introduction to MT, regardless of specific psychiatric illness or patient population. . To progress to the next level, the user must interact with every element. The training plan levels include psychoeducation and exercises (guided meditations and seated practices), which increase in duration as users progress. Levels 1,7 and 14 also include an assessment with the FFMQ-SF. The "practice now" area has guided meditations to practice new skills.
control - web MD
ACTIVE COMPARATORA a widely available health and wellness app that provides users with daily content on general health, WebMD, will serve as the attention control. Similar health-based apps have been used as controls in other mHealth psychotherapy intervention trials.100,101 The control group will be instructed to access the app 4x/week (same as intervention group) and will receive an orientation and 2 booster sessions as well. I considered other control group options including treatment as usual, but attention control was selected due to the variability of treatment as usual.
Interventions
This study will use Mindfulness Coach, an iOS- and Android-based app designed to deliver a mindfulness training course centered on Veteran's Affairs (VA) protocols. Developed by the VA's National Center for PTSD, the app provides an engaging introduction to MT, regardless of specific psychiatric illness or patient population. The app provides a training plan with 14 sequential levels, a "practice now" area with evidence-based mindfulness audio exercises, assessments using the Five-Factor Mindfulness Questionnaire Short Form (FFMQ-SF)90, and education about mindfulness. To progress to the next level, the user must interact with every element. The training plan levels include psychoeducation and exercises (guided meditations and seated practices), which increase in duration as users progress. Levels 1,7 and 14 also include an assessment with the FFMQ-SF. The "practice now" area has guided meditations to practice new skills.
A a widely available health and wellness app that provides users with daily content on general health, WebMD, will serve as the attention control. Similar health-based apps have been used as controls in other mHealth psychotherapy intervention trials.100,101 The control group will be instructed to access the app 4x/week (same as intervention group) and will receive an orientation and 2 booster sessions as well. I considered other control group options including treatment as usual, but attention control was selected due to the variability of treatment as usual.
Eligibility Criteria
You may qualify if:
- adults 60+
- Diagnosis of or caregiver for individual with serious illnesses (e.g., ESRD, Cancer, CHF, COPD, Liver Disease)
- Hads-A \> 8 for patient or caregiver
- Blessed\<6
- fluent in English
- vision and hearing does not interfere with mobile device use
- caregivers who must be 21+
- caregiver must identify as primary source of informal care for patient
- Caregiver blessed \<6
- caregiver is fluent in English
- Caregiver's vision and hearing does not interfere with mobile device use.
You may not qualify if:
- experience with mindfulness therapy in last 2 years
- not fluent in English
- vision or hearing that impairs use of mobile device
- cognitive impairment more than 6 on Blessed.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
RWJ Barnabas Outpatient Geriatric Clinics
Livingston, New Jersey, 07039, United States
RWJB Outpatient Geriatrics
Monroe, New Jersey, 08831, United States
Cancer Institute of New Jersey
New Brunswick, New Jersey, 08901, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Elissa Kozlov, PhD
Rutgers University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Instructor
Study Record Dates
First Submitted
September 7, 2021
First Posted
September 10, 2021
Study Start
April 26, 2022
Primary Completion (Estimated)
October 1, 2026
Study Completion (Estimated)
October 1, 2026
Last Updated
April 24, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share